MORPHIC HOLDING, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.07 USD | +0.32% |
|
+0.29% | -2.80% |
| 04-25 | Morphic Holding, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-19 | Morphic Holding Names Simon Cooper as Chief Medical Officer | MT |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 523.1 | 1,044 | 1,751 | 1,031 | 1,437 | 1,406 | - | - |
| Enterprise Value (EV) 1 | 523.1 | 1,044 | 1,751 | 683 | 732.2 | 853 | 878.9 | 888.4 |
| P/E ratio | -6.38 x | -22.8 x | -17.7 x | -17.3 x | -8.04 x | -7.03 x | -6.51 x | -6.15 x |
| Yield | - | - | - | - | - | - | - | - |
| Capitalization / Revenue | 30.8 x | 23.2 x | 88.5 x | 14.6 x | 2,757 x | - | - | - |
| EV / Revenue | 30.8 x | 23.2 x | 88.5 x | 9.65 x | 1,405 x | - | - | - |
| EV / EBITDA | - | - | - | - | -4.12 x | -3.72 x | -3.22 x | -2.83 x |
| EV / FCF | - | -22.4 x | - | -6.74 x | -6.45 x | -4.93 x | -4.6 x | -4.38 x |
| FCF Yield | - | -4.46% | - | -14.8% | -15.5% | -20.3% | -21.7% | -22.8% |
| Price to Book | - | - | - | - | - | - | - | - |
| Nbr of stocks (in thousands) | 30,484 | 31,125 | 36,962 | 38,553 | 49,743 | 50,094 | - | - |
| Reference price 2 | 17.16 | 33.55 | 47.38 | 26.75 | 28.88 | 28.07 | 28.07 | 28.07 |
| Announcement Date | 20-02-27 | 21-03-01 | 22-02-24 | 23-02-23 | 24-02-22 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 16.98 | 44.94 | 19.79 | 70.81 | 0.521 | - | - | - |
| EBITDA 1 | - | - | - | - | -177.6 | -229.2 | -272.6 | -314.3 |
| EBIT 1 | -46.99 | -47.18 | -95.81 | -63.4 | -178.7 | -227.6 | -250.1 | -273.3 |
| Operating Margin | -276.77% | -104.97% | -484.02% | -89.53% | -34,296.74% | - | - | - |
| Earnings before Tax (EBT) 1 | -42.42 | -45.57 | -95.54 | -58.97 | -151.7 | -202.7 | -230.6 | -249.4 |
| Net income 1 | -43.33 | -45 | -95.54 | -59.04 | -152.1 | -199 | -228.8 | -250.1 |
| Net margin | -255.22% | -100.12% | -482.68% | -83.38% | -29,192.9% | - | - | - |
| EPS 2 | -2.690 | -1.470 | -2.670 | -1.550 | -3.590 | -3.995 | -4.315 | -4.564 |
| Free Cash Flow 1 | - | -46.53 | - | -101.3 | -113.6 | -173 | -191 | -203 |
| FCF margin | - | -103.54% | - | -143.12% | -21,795.2% | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 20-02-27 | 21-03-01 | 22-02-24 | 23-02-23 | 24-02-22 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 9.556 | 2.382 | 60.24 | 2.055 | 6.135 | 0.521 | - | - | - | - | - | - | - |
| EBITDA 1 | - | - | - | - | - | - | - | - | -49.15 | -53.32 | -55.43 | -58.94 | -62.68 |
| EBIT 1 | -21.55 | -31.67 | 26.35 | -31.49 | -26.58 | -39.2 | -45.3 | -44.75 | -49.43 | -53.6 | -55.51 | -58.31 | -60.29 |
| Operating Margin | -225.47% | -1,329.64% | 43.74% | -1,532.51% | -433.27% | -7,524.95% | - | - | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -21.4 | -31.48 | 26.84 | -29.99 | -24.34 | -36.1 | -38.88 | -36.13 | -40.61 | -45.21 | -52.28 | -54.78 | -58.4 |
| Net income 1 | -21.4 | -31.48 | 26.84 | -30.02 | -24.38 | -36.14 | -39.01 | -36.21 | -40.74 | -45.29 | -49.74 | -51.59 | -54.42 |
| Net margin | -223.96% | -1,321.75% | 44.56% | -1,460.88% | -397.34% | -6,935.7% | - | - | - | - | - | - | - |
| EPS 2 | -0.5800 | -0.8500 | 0.6800 | -0.7800 | -0.6400 | -0.9000 | -0.9200 | -0.7300 | -0.9400 | -0.9100 | -0.9752 | -1.002 | -1.059 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 22-02-24 | 22-05-04 | 22-08-03 | 22-11-02 | 23-02-23 | 23-04-25 | 23-08-03 | 23-11-03 | 24-02-22 | 24-04-25 | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | - | - | - | 348 | 704 | 553 | 527 | 518 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | - | -46.5 | - | -101 | -114 | -173 | -191 | -203 |
| ROE (net income / shareholders' equity) | - | - | - | - | -29.1% | -31.9% | -54.7% | -122% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - | - | - |
| Capex 1 | - | 0.54 | 1.02 | 0.37 | 1.24 | 1 | 1.25 | 1 |
| Capex / Sales | - | 1.21% | 5.15% | 0.52% | 238.2% | - | - | - |
| Announcement Date | 20-02-27 | 21-03-01 | 22-02-24 | 23-02-23 | 24-02-22 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
28.07
USD
Average target price
56
USD
Spread / Average Target
+99.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -2.80% | 1.41B | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
- Stock Market
- Equities
- MORF Stock
- Financials Morphic Holding, Inc.
